Pacira Biosciences
PCRX
#6227
Rank
S$1.31 B
Marketcap
S$33.30
Share price
1.70%
Change (1 day)
17.47%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: S$1.31 Billion

As of July 2026 Pacira Biosciences has a market cap of S$1.31 Billion. This makes Pacira Biosciences the world's 6227th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.31 B-14.33%
2025S$1.52 B24.01%
2024S$1.23 B-40.4%
2023S$2.06 B-12.87%
2022S$2.37 B-34.46%
2021S$3.62 B5.36%
2020S$3.43 B34.37%
2019S$2.55 B5.64%
2018S$2.42 B-2.19%
2017S$2.47 B41.67%
2016S$1.74 B-56.32%
2015S$4.00 B-5.49%
2014S$4.23 B72.86%
2013S$2.45 B251.53%
2012S$0.69 B261.12%
2011S$0.19 B

End of Day market cap according to different sources

On Jul 21st, 2026 the market cap of Pacira Biosciences was reported to be:

S$1.31 Billion
by Nasdaq info icon info icon
S$1.31 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
S$1.93 B 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
S$0.15 B-87.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
S$0.89 B-32.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
S$0.59 B-54.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
S$0.11 B-91.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
S$10.47 M-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA